Stock 688639 ANHUI HUAHENG BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Anhui Huaheng Biotechnology Co., Ltd.

Equities

688639

CNE1000052M6

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
118.4 CNY +1.07% Intraday chart for Anhui Huaheng Biotechnology Co., Ltd. +10.14% -5.94%
04-22 Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% MT
04-22 Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Anhui Huaheng Biotechnology's Q1 Profit Jumps 7%
MT
Anhui Huaheng Biotechnology's 2023 Profit Jumps 40%
MT
Certain A Shares of Anhui Huaheng Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 22-APR-2024.
CI
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Rate Cut Plans Boost China Stocks; Huaheng Biotechnology Jumps 9%
MT
Huaheng Biotechnology to Set Up Subsidiary, Production Plant for 700 Million Yuan
MT
Huaheng Biotechnology Gets Rights to Ouhe Biotechnology's Biological Arginine Production Technology
MT
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tranche Update on Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback Plan announced on August 11, 2023.
CI
Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback announced on August 11, 2023, has closed with 496,600 shares, representing 0.32% for CNY 49.98 million.
CI
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tranche Update on Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback Plan announced on August 11, 2023.
CI
Anhui Huaheng Biotechnology Co., Ltd.(XSSC:688639) added to S&P Global BMI Index
CI
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has received CNY 20 million in funding from Anhui Huaheng Biotechnology Co., Ltd., Suzhou Kaifeng Zhengde Investment Management Co., Ltd.
CI
Anhui Huaheng Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
CI
Anhui Huaheng Biotechnology Co., Ltd. authorizes a Buyback Plan.
CI
Anhui Huaheng Biotechnology Acquires Marketing Rights to Ouhe Biotechnology's Phytic Acid Technology
MT
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688639 Stock
  4. News Anhui Huaheng Biotechnology Co., Ltd.